Bacteriophage lytic enzymes as alternative antimicrobials
US8962297B2 · kind B2 · utility
2Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 2010 |
| Grant date | Feb 24, 2015 |
| Priority date | — |
| Expiry date | Dec 18, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2795/10332
- WIPO fieldFood chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to isolated Clostridium perfringens bacteriophage lytic enzymes from baccteriophages CP26F and CP39O, and uses in controlling Clostridium perfringens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.